Study: CVD Patients Less Likely to Use Antidiabetic Drugs
Yale School of Medicine
The Peterson Health Technology Institute (PHTI) announced today that its initial assessments will focus on remote patient monitoring (RPM) for diabetes management and virtual musculoskeletal care.
Across Africa about two million premature deaths each year are caused by the effects of diabetes and hypertension.
Researchers at University of Galway have taken a significant step forward in the management of gestational diabetes mellitus after a clinical trial involving pregnant women provided new hope for expectant mothers suffering the condition.
An individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of researchers has warned.
Nick Burton, Ph.D., has earned a five-year, nearly $2.9 million New Innovator Award from the National Institutes of Health Common Fund to find new ways to fix or prevent insulin resistance, a key driver of Type 2 diabetes.
The decision to reach for a sugar sweetened beverage is heavily influenced by where you live, Tufts University researchers report in a new study that provides a snapshot of how adults in 185 countries imbibe sugar-sweetened beverages.
Orange, Calif. — The University of California, Irvine has launched an initiative to address the toll diabetes takes on Orange County’s Latinx community and ensure greater well-being for a population that is disproportionately affected by the disease.
First annual ResearCHLA Media Day at Children's Hospital Los AngelesObesity is a major factor in the development of chronic diseases like diabetes, heart disease and fatty liver disease, which cumulatively affect 100 million adults and nearly 15 million children in the United States.
Diabetes control can significantly improve for Latinos when a pharmacist implements an intervention that addresses these patients’ barriers to medication adherence.
Below are some of the latest headlines in the Women's Health channel on Newswise.
A newly published quality improvement study shows how a simple intervention by health care providers reduced the number of older adult patients with type 2 diabetes at risk for hypoglycemia (low blood sugar) by almost 50% and led to de-escalation of diabetes medications that cause hypoglycemia in 20% of patients.
RUDN University doctors studied what happens to oxidative and antioxidant processes in the heart during diabetes and hypertension. The work provides insight into the relationship between these processes at the molecular level and outlines possible therapeutic targets.
A new Dartmouth study in the journal Science Advances suggests that how well people with diabetes manage their blood sugar depends on their experience with the condition and their overall success in controlling their glucose levels, as well as on the season and time of day.
New research analysing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.
Poo from endangered animals could be the source of a potential new treatment for the infectious bacteria that cause diabetic foot ulcers, researchers from the University of Sheffield have found.
UNLV research shows that a simple serving of strawberries each day can boost cardiometabolic health without the need for medication.
Type 2 diabetes (T2D) is a chronic metabolic disorder that affects more than 500 million people worldwide. It is characterized by insulin resistance, a condition where the cells of the body fail to respond to insulin, resulting in hyperglycemia.
One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections.
The FDA today announced approval of a therapy giving thousands of patients hope for an alternative to amputation of their legs.
Scientists at Johns Hopkins All Children’s Hospital are shedding new light on the causes of Type 2 diabetes and offering a potential strategy for developing new therapies, or perhaps, even prevent Type 2 diabetes from developing.
Type 1 diabetes is an autoimmune disease leading to an impaired glucose metabolism and requires life-long administration of insulin. While the cause of the autoimmunity reaction is still unclear, viral infections in young children are proposed to be critical environmental factors leading to type 1 diabetes.
Advancements that could lead to earlier diagnosis and treatment for diabetic retinopathy, a common complication that affects the eyes, have been identified by a multi-department research team from Michigan State and other universities.
Bacteria that live in the intestines inhibit a molecule that limits the amount of fat absorbed, increasing weight gain in mice fed a high-sugar, high-fat diet, researchers from UT Southwestern Medical Center report. The findings, published in Science, could eventually lead to new ways to combat obesity, diabetes, and malnutrition – health problems that plague hundreds of millions worldwide.
A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists, and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RA’s) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for children’s health.
A prototype sensor that measures glucose levels in saliva could eventually offer a simple, rapid and painless way for people to monitor their diabetes, according to the KAUST researchers behind the technology.
In 2017, the teams of Massimo Terzolo and Martin Fassnacht published a study in the New England Journal of Medicine that provided evidence for the efficacy of Mitotane in the prevention of recurrence in adrenocortical carcinoma.
Erectile dysfunction (ED) is more common in older individuals with long-term Type 2 diabetes.
$9 million grant awarded to researchers with UC San Diego School of Medicine supports new study of semaglutide for liver disease.
Expert advice on nutrition delivered to patients electronically saved physicians time, improved patient satisfaction, and was reimbursable by insurance, UT Southwestern Medical Center researchers report.
E. Dale Abel, MD, PhD, chair of the Department of Medicine at the David Geffen School of Medicine at UCLA and executive medical director of the UCLA Health Department of Medicine has received the Endocrine Society Fred Conrad Koch Lifetime Achievement Award, the group’s highest honor, recognizing exceptional contributions to the field of endocrinology.
According to the results of a new study in the American Journal of Preventive Medicine, published by Elsevier, exposure to interpersonal violence throughout childhood or adulthood increases an individual’s chance of developing adult-onset diabetes by more than 20%.
Pregnant women that live in walkable communities—with more sidewalks, parks and walking paths—not only engage in more physical activity but are also more likely to experience favorable birth outcomes, according to research from the University of New Hampshire.
American Heart Association honors UC San Diego Health with multiple awards for its commitment to treating patients with heart disease and stroke.
To explore prostate cancer disparities, researchers looked to another disorder, diabetes. They conducted a clinical trial and report four biomarkers linked to a higher risk of metastatic prostate cancer in men of West African heritage. They will present their results at ACS Fall 2023.
The researchers demonstrated that glucokinase activation was effective in lowering blood glucose in mice with high-fat diet-induced obesity, while it potentially raised the risk of increasing hepatic lipid accumulation that triggered the PERK-UPR pathway. Thus, this study provides clinical reference and theoretical basis for the application of glucokinase activator (GKA) in treating patients with type 2 diabetes (or combined with non-alcoholic fatty liver disease).
A new study finds that the longer a person has type 2 diabetes, the more likely they may be to experience changes in brain structure. MRI results, researchers say, indicate the negative effects longstanding diabetes may have on brain health outcomes and emphasize the importance of preventing early onset type 2 diabetes.
In a recent study published in the journal of Genes & Diseases, researchers have discovered a compelling link between a specific gut bacterium and the progression of atherosclerosis, a leading cause of cardiovascular diseases, such as heart attack and stroke. The culprit is a microbe known as Desulfovibrio desulfuricans (D. desulfuricans), found to be responsible for increasing intestinal permeability and prompting a potent inflammatory response, contributing to the disease's progression.
Ochsner Digital Medicine will partner with Hawaii-based health plan AlohaCare to provide digital medicine services to its members. This agreement will be effective September 1, 2023, with member enrollment in digital programs available immediately after.
Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study the relationship between COVID-19 and diabetes.
Daily consumption of pecans have been shown to prevent obesity and a host of related health issues like fatty liver disease and diabetes, according to a collaborative study by Texas A&M AgriLife scientists.